Timothy P. Walbert - 31 Dec 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role: Chairman, President and CEO, Director
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 31 Dec 2021
Net transactions value: -$7,551,987
Form type: 4
Filing time: 04 Jan 2022, 16:00:24 UTC
Previous filing: 01 Dec 2021
Next filing: 06 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise	$553,500	+25,000	+5%	$22.14	529,482	31 Dec 2021	Direct
transaction	HZNP	Ordinary Shares	Sale	$7,288,974	-67,478	-13%	$108.02	462,004	31 Dec 2021	Direct	F1, F2
transaction	HZNP	Ordinary Shares	Sale	$816,513	-7,522	-1.6%	$108.55	454,482	31 Dec 2021	Direct	F1, F3
holding	HZNP	Ordinary Shares						107,739	31 Dec 2021	See footnote	F4
holding	HZNP	Ordinary Shares						100,300	31 Dec 2021	See footnote	F5
holding	HZNP	Ordinary Shares						31,196	31 Dec 2021	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Stock Option (Right to Buy)	Options Exercise	$0	-25,000	-2.4%	$0.000000	1,017,565	31 Dec 2021	Ordinary Shares	25,000	$22.14	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.475 to $108.465 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F5	The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F6	The stock option is fully vested and exercisable.